Immatics Z Score

IMTX Stock

USD 9.78 0.00 0.00%

Altman Z Score is one of the simplest fundamental models to determine how likely your company is to fail. The module uses available fundamental data of a given equity to approximate the Altman Z score. Altman Z Score is determined by evaluating five fundamental price points available from the company's current public disclosure documents. Check out Immatics Piotroski F Score and Immatics Valuation analysis.

Immatics Return on Invested Capital is fairly stable at the moment as compared to the past year. Immatics reported Return on Invested Capital of 0.72 in 2022. Invested Capital is likely to rise to about 178.9 M in 2023, whereas Capital Expenditure is likely to drop (6.6 M) in 2023. Immatics Consolidated Income is fairly stable at the moment as compared to the past year. Immatics reported Consolidated Income of 37.51 Million in 2022. Earning Before Interest and Taxes EBIT is likely to rise to about 45.4 M in 2023, whereas Operating Expenses is likely to drop slightly above 127.8 M in 2023.

Immatics Z Score Analysis

Immatics' Z-Score is a simple linear, multi-factor model that measures the financial health and economic stability of a company. The score is used to predict the probability of a firm going into bankruptcy within next 24 months or two fiscal years from the day stated on the accounting statements used to calculate it. The model uses five fundamental business ratios that are weighted according to algorithm of Professor Edward Altman who developed it in the late 1960s at New York University..

	2020	2021	2022	2023 (projected)
Current Assets	238.99 M	152.21 M	377.15 M	308.23 M
Total Assets	254.65 M	174.65 M	407.82 M	334.22 M

Current Assets Total Assets

Z Score

Sum Of

5 Factors

More About Z Score | All Equity Analysis

Current Immatics Z Score

27.49

Most of Immatics' fundamental indicators, such as Z Score, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Immatics NV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

First Factor

1.2 * (

Working Capital

Total Assets )

Second Factor

1.4 * (

Retained Earnings

Total Assets )

Thrid Factor

3.3 * (

EBITAD

Total Assets )

Fouth Factor

0.6 * (

Market Value of Equity

Total Liabilities )

Fifth Factor

0.99 * (

Revenue

Total Assets )

Immatics Z Score Driver Correlations

Understanding the fundamental principles of building solid financial models for Immatics is extremely important. It helps to project a fair market value of Immatics Stock properly, considering its historical fundamentals such as Z Score. Since Immatics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Immatics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Immatics' interrelated accounts and indicators.

To calculate a Z-Score, one would need to know a company's current working capital, its total assets and liabilities, and the amount of its latest earnings as well as earnings before interest and tax. Z-Scores can be used to compare the odds of bankruptcy of companies in a similar line of business or firms operating in the same industry. Companies with Z-Scores above 3.1 are generally considered to be stable and healthy with a low probability of bankruptcy. Scores that fall between 1.8 and 3.1 lie in a so-called 'grey area,' with scores of less than 1 indicating the highest probability of distress. Z Score is a used widely measure by financial auditors, accountants, money managers, loan processors, wealth advisers, and day traders. In the last 25 years, many financial models that utilize z-scores proved it to be successful as a predictor of corporate bankruptcy.

Competition

Predict Immatics

According to the company's disclosures, Immatics NV has a Z Score of 27.49. This is 307.26% higher than that of the Healthcare sector and notably higher than that of the Biotechnology industry. The z score for all United States stocks is notably lower than that of the firm.

Immatics Z Score Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Immatics' direct or indirect competition against its Z Score to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Immatics could also be used in its relative valuation, which is a method of valuing Immatics by comparing valuation metrics of similar companies.

Immatics is currently under evaluation in z score category among related companies.

Immatics Fundamentals

	Return On Equity	(0.43) %
	Return On Asset	(0.12) %
	Profit Margin	(0.85) %
	Operating Margin	(0.81) %
	Current Valuation	427.48 M
	Shares Outstanding	76.67 M
	Shares Owned by Insiders	26.02 %
	Shares Owned by Institutions	46.77 %
	Number of Shares Shorted	4.42 M
	Price to Earning	44.61 X
	Price to Book	6.18 X
	Price to Sales	4.70 X
	Revenue	172.83 M
	Gross Profit	172.83 M
	EBITDA	46.34 M
	Net Income	37.51 M
	Cash and Equivalents	324.38 M
	Cash per Share	5.00 X
	Total Debt	16.41 M
	Debt to Equity	0.13 %
	Current Ratio	2.95 X
	Book Value Per Share	2.61 X
	Cash Flow from Operations	100.13 M
	Short Ratio	8.34 X
	Earnings Per Share	(1.19) X
	Price to Earnings To Growth	3.00 X
	Target Price	18.02
	Number of Employees	402
	Beta	0.48
	Market Capitalization	755.21 M
	Total Asset	407.82 M
	Retained Earnings	(500.3 M)
	Working Capital	270.7 M
	Z Score	27.49
	Net Asset	407.82 M

About Immatics Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Immatics NV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Immatics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Immatics NV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 388 people.

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Immatics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Immatics' short interest history, or implied volatility extrapolated from Immatics options trading.

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Immatics NV using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

Check out Immatics Piotroski F Score and Immatics Valuation analysis. You can also try Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Complementary Tools for Immatics Stock analysis

When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.

	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Bond Directory Find actively traded corporate debentures issued by US companies
	Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges
	ETF Directory Find actively traded Exchange Traded Funds (ETF) from around the world
	Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
	Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators
	Portfolio Anywhere Track or share privately all of your investments from the convenience of any device
	Commodity Channel Index Use Commodity Channel Index to analyze current equity momentum
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Is Immatics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immatics. If investors know Immatics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immatics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(1.19)

Revenue Per Share

1.128

Quarterly Revenue Growth

(0.91)

Return On Assets

(0.12)

Return On Equity

(0.43)

The market value of Immatics NV is measured differently than its book value, which is the value of Immatics that is recorded on the company's balance sheet. Investors also form their own opinion of Immatics' value that differs from its market value or its book value, called intrinsic value, which is Immatics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immatics' market value can be influenced by many factors that don't directly affect Immatics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Immatics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Immatics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immatics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. Check out Immatics Piotroski F Score and Immatics Valuation analysis.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

	Total Assets	Current Assets	Cash and Equivalents	Total Debt	Debt Current	Deferred Revenue	Investments Current	Total Liabilities	Current Liabilities
Total Assets		1.0	0.87	0.84	0.36	0.82	0.86	0.91	0.93
Current Assets	1.0		0.87	0.85	0.37	0.82	0.86	0.91	0.92
Cash and Equivalents	0.87	0.87		0.95	0.69	0.85	0.54	0.92	0.9
Total Debt	0.84	0.85	0.95		0.78	0.68	0.55	0.77	0.78
Debt Current	0.36	0.37	0.69	0.78		0.37	-0.03	0.38	0.33
Deferred Revenue	0.82	0.82	0.85	0.68	0.37		0.6	0.97	0.87
Investments Current	0.86	0.86	0.54	0.55	-0.03	0.6		0.68	0.7
Total Liabilities	0.91	0.91	0.92	0.77	0.38	0.97	0.68		0.97
Current Liabilities	0.93	0.92	0.9	0.78	0.33	0.87	0.7	0.97

Immatics Z Score

Immatics Z Score Analysis

Current Immatics Z Score

Immatics Z Score Driver Correlations

Immatics Z Score Peer Comparison

Immatics Fundamentals

About Immatics Fundamental Analysis

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Immatics Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY